Document is current
Any future updates will be listed below
-
Authors
Sánchez-Rivera, Francisco J.
Diaz, Bianca J. http://orcid.org/0000-0002-5309-1300
Kastenhuber, Edward R. http://orcid.org/0000-0002-1872-212X
Schmidt, Henri http://orcid.org/0000-0002-0132-3472
Katti, Alyna
Kennedy, Margaret http://orcid.org/0000-0001-9106-1906
Tem, Vincent
Ho, Yu-Jui
Leibold, Josef
Paffenholz, Stella V.
Barriga, Francisco M. http://orcid.org/0000-0002-0996-7707
Chu, Kevan
Goswami, Sukanya
Wuest, Alexandra N.
Simon, Janelle M.
Tsanov, Kaloyan M.
Chakravarty, Debyani
Zhang, Hongxin
Leslie, Christina S. http://orcid.org/0000-0002-4571-5910
Lowe, Scott W. http://orcid.org/0000-0002-5284-9650
Dow, Lukas E. http://orcid.org/0000-0001-7048-1418
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (F31-CA261061-01, F31-CA192835, F31-CA247351-02, 5T32CA160001-08, P01 CA087497, R01CA229773-01A1)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Jane Coffin Childs Memorial Fund for Medical Research
U.S. Department of Health & Human Services | National Institutes of Health
Howard Hughes Medical Institute
Agilent Technologies
U.S. Department of Health & Human Services | National Institutes of Health
- License Information
-
More Information
Article History
Received: 2 July 2021
Accepted: 29 November 2021
First Online: 14 February 2022
Competing interests
: L.E.D. is a scientific advisor and holds equity in Mirimus Inc. and is a consultant for Volastra Therapeutic and Fraizer Healthcare S.W.L. is an advisor for and has equity in the following biotechnology companies: ORIC Pharmaceuticals, Faeth Therapeutics, Blueprint Medicines, Geras Bio, Mirimus Inc. and PMV Pharmaceuticals. S.W.L. acknowledges receiving funding and research support from Agilent Technologies for the purposes of massively parallel oligo synthesis. The remaining authors declare no competing interests.
